Tsakonas, G.; MartÃn-Bernabé, A.; Rounis, K.; Moreno-Ruiz, P.; Botling, J.; De Petris, L.; Ylipää, A.; Mezheyeuski, A.; Micke, P.; Östman, A.;
et al. High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC. Cancers 2021, 13, 3151.
https://doi.org/10.3390/cancers13133151
AMA Style
Tsakonas G, MartÃn-Bernabé A, Rounis K, Moreno-Ruiz P, Botling J, De Petris L, Ylipää A, Mezheyeuski A, Micke P, Östman A,
et al. High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC. Cancers. 2021; 13(13):3151.
https://doi.org/10.3390/cancers13133151
Chicago/Turabian Style
Tsakonas, Georgios, Alfonso MartÃn-Bernabé, Konstantinos Rounis, Pablo Moreno-Ruiz, Johan Botling, Luigi De Petris, Antti Ylipää, Artur Mezheyeuski, Patrick Micke, Arne Östman,
and et al. 2021. "High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC" Cancers 13, no. 13: 3151.
https://doi.org/10.3390/cancers13133151
APA Style
Tsakonas, G., MartÃn-Bernabé, A., Rounis, K., Moreno-Ruiz, P., Botling, J., De Petris, L., Ylipää, A., Mezheyeuski, A., Micke, P., Östman, A., & Ekman, S.
(2021). High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC. Cancers, 13(13), 3151.
https://doi.org/10.3390/cancers13133151
